Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia

NCT07585968 is registered in ClinicalTrials.gov with Medtronic Cardiac Ablation Solutions as lead sponsor.

NCT NCT07585968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia
Lead sponsor
Medtronic Cardiac Ablation Solutions
Phase
Not applicable
Overall status
Recruiting
Start date
August 17, 2026
Completion date
September 30, 2028
Enrollment
260 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia